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Abstract
Increased phosphorylation of the 70 kDa ribosomal S6 kinase (p70s6k) signaling is strongly
correlated with the degree of muscle adaptation following exercise. Here, we compare the
phosphorylation of p70s6k, Akt and mTOR in the tibialis anterior (TA) muscles of lean and obese
Zucker rats following a bout of eccentric exercise. Exercise increased p70S6k (Thr 389)
phosphorylation immediately after (33.3 ± 7.2%) and during recovery [1-hr; (24.0 ± 14.9%), and
3-hr (24.6 ± 11.3%)], in the lean TA and at 3-hr (33.5 ± 8.0%) in the obese TA. mTOR (Ser 2448)
phosphorylation was elevated in the lean TA immediately after exercise (96.5 ± 40.3%) but
remained unaltered in the obese TA. Exercise increased Akt (Thr 308) and Akt (Ser 473)
phosphorylation in the lean but not the obese TA. These results suggest that insulin resistance is
associated with alterations in the ability of muscle to activate p p70s6k signaling following an
acute bout of exercise.
Keywords
Skeletal muscle; insulin resistance; obese Zucker rat; p70S6k; mTOR
INTRODUCTION
Type 2 (non-insulin dependent) diabetes mellitus (DM) is an emerging epidemic in Western
cultures that is thought to afflict 150 million people worldwide 11. Insulin resistance is
frequently accompanied by a variety of metabolic and cardiovascular abnormalities that
include hypertension, glucose intolerance, Type 2 diabetes, dyslipidemia, atherosclerosis
and central obesity. A number of studies that employ strength training regimens have been
shown to improve glycemic control, increase skeletal muscle size and strength, and
positively change body composition. They suggest that anaerobic exercise may be an
effective strategy for the treatment of insulin resistance and type 2 diabetes 6,7,49,53.
Recent reports have suggested that differences exist between normal and insulin resistant
muscle in their adaptation to an exercise regimen 8,5,50,20,24,48. However, the direct
effects of exercise on the phenotype of insulin resistant muscle have not been widely

Author for correspondence: Eric R. Blough, Ph.D., Laboratory of Molecular Physiology, Byrd Biotechnology Building, 1 John
Marshall Drive, Marshall University, Huntington, WV 25755-1090, blough@marshall.edu.

Katta et al.

Page 2

studied. It is thought that the beneficial effects of exercise on muscle are mediated through
activation of various signaling cascades which are involved in regulating changes in gene
expression, glucose uptake, and protein synthesis 2. Whether insulin resistance alters
exercise-induced signal transduction processes in muscle is unknown, but the existence of
differences, if present, may help to explain why exercise-induced skeletal muscle
adaptations may differ between normal and insulin resistant populations.
It is well established that increased muscle loading increases the rates of muscle protein
synthesis 27. This increase in protein synthesis, at least in part, is thought to be regulated by
the phosphorylation of the p70 ribosomal protein S6 kinase (p70S6k) 26, whose activation
has been proposed to promote increased translation of messages that have a polypyrimide
motif just downstream of the 5′ cap 45. It is thought that p70S6k activity is regulated by the
mammalian target of rapamycin (mTOR), which functions as a growth factor and nutrientsensing signaling molecule in mammalian cells 40. How mTOR activity is modulated is not
clear; however, recent evidence suggests that mTOR is controlled by Akt or protein kinase B
(PKB) which is activated in response to phospholipid products of the phosphatidylinositol 3kinase (PI3K) reaction. It is well documented that binding of insulin to the membrane
receptor stimulates a cascade of phosphorylation events resulting in activation of PI3K. It is
likely that PKB/Akt directly increases mTOR activity by phosphorylating mTOR at
Ser2448, and it has been hypothesized that this event is a critical point of control in the
regulation of protein synthesis 4. It has been postulated that p70S6k signaling may be
particularly important in mediating muscle adaptation given that the phosphorylation of this
molecule following an exercise bout has been found to be strongly associated with the
increase in muscle weight after 6 wk of chronic stimulation 1
The purpose of the present study was to determine whether insulin resistance alters p70S6k
signaling after an acute episode of contractile activity. To investigate this possibility, muscle
signaling was examined in 12-week old lean and obese Zucker rats, as it is widely accepted
that the insulin resistance exhibited by these animals closely models the development of type
2 diabetes seen in humans 3,18,25,39. We hypothesized that insulin resistance would be
associated with differences in how muscle contraction regulates the phosphorylation of the
Akt/mTOR/p70S6k signaling cascade. To test this hypothesis, the contraction-mediated
activation of Akt, mTOR and p70S6k was assessed either immediately after or 1 or 3h after
a single bout of sciatic nerve stimulation. Taken together, our data suggest that insulin
resistance alters contraction-induced p70S6k phosphorylation in skeletal muscle. These
findings are consistent with the possibility that insulin resistance alters the way skeletal
muscle “senses and responds” to contractile stimuli.

METERIALS AND METHODS
Animal Care
All procedures were performed as outlined in the Guide for the Care and Use of Laboratory
Animals as approved by the Council of the American Physiological Society and the Animal
Use Review Board of Marshall University. Young (10 week, n=12) male lean Zucker and
young (10 week, n=12) male obese Zucker rats were obtained from the Charles River
Laboratories. Rats were housed two to a cage in an Association for Assessment and
Accreditation of Laboratory Animal Care (AAALAC) approved vivarium. Housing
conditions consisted of a 12H: 12H dark-light cycle, and temperature was maintained at 22°
± 2°C. Animals were provided food and water ad libitum and allowed to recover from
shipment for at least two weeks before experimentation. During this time the animals were
carefully observed and weighed weekly to ensure that none exhibited signs of failure to
thrive, such as precipitous weight loss, disinterest in the environment, or unexpected gait
alterations.
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Materials
Anti- p70S6k (#9202), Akt (#9272), mTOR (#2972), PTEN (#9552), TSC2/tuberin (#3612),
raptor (#4978), phosphorylated Thr389 p70S6K (#9206), phosphorylated Ser421/Thr424
p70S6K (#9204), phosphorylated Ser2448 mTOR (#2971), phosphorylated Thr308 Akt
(#9275), phosphorylated Ser473 ( #9271) Akt, Ser380/Thr382/383 phosphorylated PTEN
(#9554), phosphorylated Thr1462 TSC2/tuberin (#3611), Mouse IgG, and Rabbit IgG
antibodies were purchased from Cell Signaling Technology (Beverly, MA). Enhanced
chemiluminescence (ECL) western blotting detection reagent was obtained from Amersham
Biosciences (Piscataway, NJ). Restore western blot stripping buffer was obtained from
Pierce Company (Rockford, IL), and 3T3 cell lysates were from Santa Cruz Biotechnology
(Santa Cruz, CA). All other chemicals were purchased from Sigma Biosciences (St. Louis,
MO) or Fisher Scientific Company (Hanover, IL).
Contractile stimulation of skeletal muscles
The high-frequency electrical stimulation (HFES) model has been previously described 36
and was chosen on the basis of its efficacy in stimulating protein translation and muscle
hypertrophy in vivo1. In order to produce maximal contractile stimulus, a voltage of 5–7V
was applied to electrodes placed on the sciatic nerve and the sciatic nerve was stimulated
with 1-ms pulses at 100 Hz, where all motor units(both fast and slow) are recruited. The
contractionslasted 3 s and were followed by a 10-s rest, and after the sixth repetition there
was an additional 50 s of rest. The HFES model used in the present study produced 10 sets
of 6 contractions with an overall protocol time of 22 min. This protocol results in eccentric
contraction of the TA. The TA muscle was chosen for analysis on the basis of previous
studies demonstrating that HFES induces p70S6k phosphorylation and muscle hypertrophy
in the TA muscle 15,30,47,54. Animals were killed by a lethal dose of pentobarbital sodium
at baseline, immediately following, 1h or 3 h after HFES. Once excised, muscles were
blotted dry, trimmed of visible fat and tendon projections, weighed, immediately frozen in
liquid nitrogen, and stored at −80° C.
Preparation of protein isolate and immunoblotting
Muscles were pulverized in liquid nitrogen using a mortar and pestle until a fine powder was
obtained. After washing with ice cold PBS, pellets were lysed on ice for 15 minutes in
Tissue Protein Extraction Reagent (T-PER) lysis buffer composed of T-PER reagent (2mL/
1g tissue weight) (Pierce, Rockford, IL), 1 mM EDTA (pH 8.0), 1 mM EGTA (pH 7.5), 1M
magnesium chloride, 1 mM PMSF, 1μl protease inhibitor cocktail and 1 mM sodium
vanadate to inhibit phosphatase activity and centrifuged for 10 minutes at 2000 × g to pellet
particulate matter. This process was repeated twice, and the supernatants were combined for
protein concentration determination using the Bradford method (Pierce, Rockford, IL).
Samples were diluted to a concentration of 3 μg/ μl in SDS loading buffer and boiled for 5
minutes. 60 μg of protein were separated using 10% SDS-PAGE gels. Transfer of protein
onto nitrocellulose membranes, verification of transfer and determination of equal loading
between lanes and membranes was determined as outlined previously 33. Protein immunodetection was performed as outlined by the antibody manufacturer while immunoreactive
bands were visualized with Electrochemiluminescence (ECL) (Amersham Biosciences).
Exposure time was adjusted at all times to keep the integrated optical densities (IODs)
within a linear and non-saturated range, and band signal intensity was quantified by
densitometry using a flatbed scanner (Epson Perfection 3200 PHOTO) and imaging software
(AlphaEaseFC) after normalization to β-tubulin. Molecular weight markers (Cell Signaling)
were used as molecular mass standards, and NIH 3T3 cell lysates were included as positive
controls. To allow direct comparisons to be made between the concentration levels of
different signaling molecules, immunoblots were stripped and re-probed with Restore
western blot stripping buffer as detailed by the manufacturer (Pierce, Rockford, IL).
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Statistical analysis
Results are presented as mean ± SEM. Data were analyzed by using the Sigma Stat 3.0
statistical program. Data was analyzed using a two-way ANOVA followed by the StudentNewman-Keuls post-hoc testing when appropriate. P <0.05 was considered to be statistically
significant.
RESULTS
Insulin resistance and muscle mass
The average body weight of the obese Zucker rats was ~82 % greater than that of the lean
Zucker rats (597 ± 21.7 g vs. 328 ± 12.2 g; P< 0.05). Compared to lean animals, TA muscle
mass was ~35% less (651 ± 9.0 mg vs. 479 ± 20 mg) in the obese Zucker rats (P< 0.05)
(Table 1).

P70S6k pathway related protein levels and phosphorylation status are altered in the insulin
resistant TA muscle
To investigate the effects of insulin resistance on the total amounts of p70S6k, mTOR, Akt,
PTEN, TSC2 and raptor we performed SDS PAGE and western blot analysis using
antibodies which recognize both the unphosphorylated and phosphorylated forms of these
molecules. There were no differences in mTOR, raptor and TSC2 protein content (P< 0.05)
(Figs.1, 5). The muscle content of p70S6k, and Akt in the obese zucker TA was 27.9 ± 3.6%
and 28.2 ± 10.1% lower, respectively than that observed in their lean counterparts (P< 0.05)
(Fig. 1). The expression of PTEN was higher in obese Zucker rats by 25.63 ± 4.2% when
compared to the lean Zucker rats (P< 0.05) (Fig. 5). Immunoblot analysis using phosphospecific antibodies indicated that the basal phosphorylation level of p70S6k (Thr 389) was
26.1 ± 7.5% lower in the obese Zucker TA compared to that observed in lean animals
(P<0.05) (Fig. 2). No differences were seen across groups in basal phosphorylation levels of
p70S6k (Thr421/Ser424), mTOR (Ser 2448), Akt (Thr 308) Akt (Ser 473) and TSC2 (Figs.
2, 3, 4 and 5).

The contraction-induced phosphorylation of p70S6k is altered in the obese-Zucker rat
Phosphorylation of p70S6k, mTOR and Akt in exercised TA muscles was determined at 0-,
1-, and 3-hours after a bout of HFES and compared to control (unstimulated) muscles.
Exercise-induced phosphorylation of these molecules was compared between lean and obese
Zucker rats. In the case of each molecule examined, significant differences existed between
lean and obese Zucker rats (Fig. 2, 3 & 4). In the lean rat TA, the phosphorylation of p70S6k
(Thr 389) was found to be 33.3 ± 7.2%, 24.0 ± 14.9% and 24.6 ± 11.3% higher than in
unstimulated control muscles at 0-, 1- and 3-hr post-HFES, respectively (P< 0.05) (Fig. 2).
This response appeared to differ in the obese Zucker TA, where the phosphorylation of
p70S6k (Thr 389) was 33.5 ± 8.0% higher than control 3hr post-exercise (P<0.05), but not
immediately after or at the 1 hr post-HFES (Fig. 2). In lean Zucker TA, the Erk1/2dependent phosphorylation of p70S6k (Thr 421/Ser 424) was 412.5 ± 37.2%, 331.0 ± 28.1%
and 83.0 ± 20.7% higher than control at 0-, 1- and 3-hr, respectively (P< 0.05) (Fig. 2).
Although different in magnitude compared to lean animals (Fig. 2) p70S6k (Thr 421/Ser
424 ) phosphorylation in the obese TA exhibited a similar pattern and was 294.5 ± 9.6%,
103.3 ± 35.5% and 182.0 ± 26.1% higher than baseline at 0-, 1- and 3-hours, respectively
(Fig 2; P< 0.05)
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Contraction-induced phosphorylation of potential p70S6k regulators is
altered in the obese Zucker rat
It is thought that p70S6k phosphorylation is regulated by the mTOR complex and its
upstream regulator Akt 4,40,41. mTOR phosphorylation (Ser 2448) was found to be 96.5 ±
40.3% higher than baseline immediately after exercise in lean animals (P< 0.05), while it
was not different from baseline at 1 and 3 hr post-HFES (Fig. 3). This response differed in
obese animals with no alteration in mTOR (Ser 2448) phosphorylation levels at any time
point after HFES (Fig. 3). There was no significant difference between contraction-induced
TSC2 (Thr 1462) phosphorylation in obese Zucker rats compared to their lean counterparts
(Fig. 5). In the lean Zucker TA, Akt (Thr 308) phosphorylation was 31.8 ± 16.2%, 29.8 ±
7.5% and 31.1 ± 8.8% higher than baseline at 0-, 1- and 3-hr post-HFES, exhibiting a
biphasic response (P<0.05; Fig. 4). An altogether opposite response was observed in the
obese Zucker TA, where Akt (Thr 308) phosphorylation was 25.3 ± 6.2%, 44.6 ± 9.0% and
30.4 ± 5.9% lower than baseline at 0-, 1-, and 3-hours, respectively after HFES (P<0.05). In
lean rats the phosphorylation of Akt (Ser 473) appeared to mirror what was seen at the Thr
308 residue with HFES and was 47.2 ± 12.1% and 43.7 ± 11.7% higher than baseline at 0and 3-hours, respectively (P< 0.05) (Fig. 4). This pattern of response was essentially
opposite in the obese Zucker rats, where the phosphorylation of Akt (Ser 473) was 18.7 ±
6.4%, 46.3 ± 5.5% and 32.4 ± 7.3% lower than baseline at 0-, 1-, and 3-hours post-HFES,
respectively (P< 0.05) (Fig. 4). Taken together these results suggest that the contractioninduced activation of p70S6k signaling may be altered with insulin resistance.

DISCUSSION
The obese Zucker rat is insulin resistant and has been used as a model of type 2 diabetes
10,22. In this report we demonstrate that the phosphorylation (activation) of the Akt/mTOR/
p70S6k pathway in response to a maximal contractile stimulus appears to be altered in
insulin resistant muscle.
Our results suggest that, compared to lean animals, the magnitude and time course of the
contraction-induced phosphorylation of p70S6k (Thr 389) and p70S6k (Thr 421/ser 424)
was significantly different in obese animals (Fig. 2). The p70S6k is a serine/threonine
protein kinase, and it has been shown to play an important role in regulating protein
synthesis. It is thought that p70S6k modulates protein synthesis, at least in part, by
controlling the translation of numerous messenger RNA transcripts that encode components
of the translational apparatus 38. Illustrating this fact is the finding that blockade of p70S6k
activity results in significant inhibition of protein synthesis in multiple cell systems
12,23,9,32,55. In skeletal muscle, the contraction-induced phosphorylation of p70S6K has
been found to be elevated following HFES 1,37,36 and is highly correlated with an increase
in muscle mass following a resistance training program 1. To our knowledge, the influence
of diabetes on p70S6k phosphorylation in response to muscle contraction has not been
reported before. The physiological significance of these alterations remains unclear;
however it is interesting to note that previous reports have suggested that the insulinstimulated phosphorylation of p70S6k may be altered in diabetic rats 19,14,29. In the light
of these studies, our data suggest that insulin resistance may affect how multiple stimuli may
regulate the phosphorylation of p70S6k. Future studies that employ a combination of
approaches to stimulate p70S6k phosphorylation will certainly be of value in determining
how insulin resistance may affect the regulation of p70S6k in skeletal muscle.
To further explore how insulin resistance may be associated with alterations in the
contraction-induced regulation of p70S6k phosphorylation, we assessed the effects of
muscle contraction on mTOR. Like p70S6k, mTOR is thought to be involved in regulating
several components of the translational machinery and in addition, it is thought to be an
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upstream activator of p70S6k 16. Similar to previous studies, increased contractile activity
appears to be a strong stimulus to increase the phosphorylation level of mTOR in nondiabetic muscle 37,36. Conversely, in the insulin resistant TA, HFES appears to be unable to
alter the degree of mTOR phosphorylation (Fig. 3). This latter finding is consistent with our
data that demonstrate that insulin resistant muscle exhibits a reduced ability to activate
p70S6k following a bout of HFES. Taken together, these data suggest that insulin resistanceassociated alterations in p70S6k regulation may be due, at least in part, to defects in the
ability of diabetic muscle to activate mTOR following a contractile stimulus.
It is thought that mTOR phosphorylation of Ser 2448 is directly regulated by Akt/PKB
41,43,44. Akt is a serine/threonine kinase that has been shown to mediate certain types of
muscle hypertrophy 4. Under non-stimulated conditions Akt is located in the cytoplasm. It is
thought to translocate to the plasma membrane upon activation, where it is phosphorylated
by phosphinositide-dependent kinases (PDK) on its two principal regulatory sites Thr 308
and Ser 47352. Like p70S6k and mTOR, HFES significantly increased the amount of Akt
(Ser 308) and Akt (Ser 473) phosphorylation in non-diabetic muscle (Fig 4). Similar
findings regarding the effects of contractile activity on Akt phosphorylation in non-insulin
resistant muscle have been reported previously 34,42,51. In contrast to our findings in the
non-insulin resistant animals, these events appeared to differ in insulin resistant muscle. This
suggests that insulin resistance is associated with alterations in the ability of skeletal muscle
to activate Akt signaling following increased contractile loading (Fig. 4). Given that Akt is
thought to reside upstream of mTOR, this lack of Akt activation in insulin resistant muscle
may provide an explanation as to why insulin resistance may be associated with defects in
HFES induced mTOR and p70S6k phosphoryation.
In an attempt to explain differences in contraction-dependent signaling between models we
also examined how HFES affected the regulation of raptor (a positive regulator of mTOR
activity), the Akt inhibitor, phosphatase and tensin homolog (PTEN), and the mTOR
repressor, tuberin (TSC2) 28. The ability of PTEN and TSC2 to inhibit downstream
signaling is thought to be regulated by phosphorylation 57,56 while differences in raptor
levels between models could influence mTOR activation. Our findings of no differences in
the regulation of these three molecules with HFES between models suggests that raptor,
PTEN and tuberin may not be responsible for the differences in Akt and mTOR
phosphorylation that we observe between normal and insulin-resistant muscle subjected to
HFES (Fig. 5). Although not investigated here, recent work has suggested that
phospholipase D (PLD) may play a key role in regulating load-induced mTOR
phosphorylation in skeletal muscle 21. Whether differences in PLD regulation with insulin
resistance can explain the alterations in mTOR signaling we see between our experimental
models will require further experimentation (Fig. 6).
The precise influence of insulin resistance on Akt regulation in muscle contraction remains
unclear. It has been postulated that the degree of Akt activation following contractile activity
may be dependent upon the type of contractile activity, contraction intensity, and/or the
duration of stimulation 36. Given this contention, it is plausible that differences in the
signaling response between models could be related to the time points chosen for evaluation.
Future studies that employ other time points could yield different findings. Alternatively, it
is possible that the two groups experienced a different amount of tension during the HFES
protocol. Although this possibility exists, we consider it unlikely that differences in
contractile intensity, if present, are solely responsible for the alterations in muscle signaling
we observe. Indeed, given the nature of the HFES model (direct nerve stimulation), the type
of contraction this model produces in the TA (maximal eccentric loading) and the conditions
under which the loading occurred (identical in both groups), we suggest that our data are
consistent with the notion that insulin resistance is characterized by alterations in contractile
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signaling. The molecular mechanism(s) responsible for these differences are largely
unknown. Exercise was found to have no effect on Akt as observed in isolated soleus
muscle, suggesting perhaps that systemic factors and/or oxidative stress may also play a role
in mediating the activation of Akt by exercise 46. Supporting this contention, hyperglycemia
has been shown to directly decrease insulin-induced Akt phosphorylation on Ser473 in rat
and human skeletal muscle 17,35. The factors which may regulate diminished Akt activation
during hyperglycemia will require further experimentation. Similarly, it is also possible that
reduced availability of circulating growth factors, decreased expression of local growth
factors or alterations in cytokine levels may also play a role regulating Akt signaling 31.
This latter possibility is an intriguing alternative that we are actively pursuing. Given the
strong correlation between the phosphorylation level of p70S6k and degree of muscle
hypertrophy seen by others, these data could suggest that insulin resistant muscle may be
incapable of growth following a resistance-based exercise program. This is not in agreement
with the findings of Farrell and colleagues who demonstrated that diabetic muscle is fully
capable of undergoing muscle hypertrophy following 8 weeks of resistance training13. The
reasons for this apparent discrepancy are not entirely clear, but they may lie in the difference
in models and time points of the studies. Irrespective of the mechanism, it is likely that
insulin resistance-associated differences in the ability of skeletal muscle to induce Akt →
mTOR → p70S6K signaling could be of clinical importance, given the potential role that
this signaling pathway may play in regulating protein synthesis and the adaptation of
skeletal muscle to increased contractile loading (Fig. 6). Given the apparent linkage between
exercise-induced increase in muscle mass and improvement in glucose disposal, we
speculate that the data of the present study may have implications for the improvement of
resistance based programs for the treatment of diabetes mellitus.
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Abbreviations
ECL

Enhanced Chemiluminiscence

HFES

High Frequency Electrical Stimulation

LZ

Lean Zucker

mTOR

mammalian Target of Rapamycin

PBS

Phosphate Buffered Saline

PTEN

Phosphatase and Tensin Homolog

OZ

Obese Zucker

p70S6k

70 kDa ribosomal S6 kinase

PKB

Protein Kinase B

SDS-PAGE

Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis

TA

Tibialis Anterior

T-PER

Tissue Protein Extraction Reagent

TSC2

Tuberous Sclerosis Complex 2
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Figure 1.

TA muscles from lean (LNZ) and obese Zucker rats (OSXZ) were analyzed by Western blot
analysis for diabetes-related changes in total p70S6k, mTOR and Akt protein expression.
Protein quantifications were done after normalization by the abundance of β-tubulin protein.
Results are expressed as a percent of the normal, LNZ value. An asterisk (*) indicates
significant differences (P< 0.05) from the lean Zucker value.
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Figure 2. Contraction-induced p70S6k (Thr 389 & Thr 421/Ser 424) phosphorylation is altered
with insulin resistance

The basal (control) and contraction-induced phosphorylation of p70S6k in TA muscles from
lean and obese Zucker rats at 0, 1, and 3 hours after contractile stimulus. p70S6k (Thr 389 &
Thr 421/ser 424) phosphorylation was determined by Western blot analysis and
immunodetection for phosphorylation on Thr389 andThr421/Ser424. All the protein
quantifications were done after normalization by the abundance of β-tubulin protein. An
asterisk (*) indicates a significant difference (P < 0.05) from the control within-animal
model, and a cross (†) indicates significant difference (P < 0.05) at corresponding time
points across animal models.
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Figure 3. Contraction-induced mTOR (Ser2448) phosphorylation is altered with insulin
resistance

The basal (control) and contraction-induced phosphorylation of the mTOR in TA muscles
from lean (LNZ) and obese Zucker (OSXZ) rats at 0-, 1-, and 3-hours after HFES.
Phosphorylation of mTOR was determined by immunodetection of phosphorylation on
Ser2448. An asterisk (*) indicates significant difference (P < 0.05) from the control time
point within-animal model, and a cross (†) indicates a significant difference (P < 0.05) at
corresponding time points across animal models.
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Figure 4. Effects of eccentric, maximal muscle contraction in situ on phosphorylation of Akt
(Thr308/Ser473)

The basal (control) and contraction-induced phosphorylation of the Akt in TA muscles from
lean and obese Zucker rats at 0, 1, and 3 hours after contractile stimulus. Akt
phosphorylation was determined by Western analysis and immunodetection for Akt
phosphorylation on Thr308 and Ser473. An asterisk (*) indicates significant difference (P <
0.05) from the control within-animal model, and a cross (†) indicates significant difference
(P < 0.05) at corresponding time points across animal models.
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Figure 5.

Immunoblot analyses of Protein abundance of Raptor, TSC2 and PTEN and phosphorylation
of Thr1462 on TSC2 and Phosphorylation of Ser380/Thr382/383 on PTEN in TA muscles
from lean and obese Zucker rats at 0, 1, and 3 hours after contractile stimulus.
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Figure 6.

Schematic diagram summarizing alterations in molecules of the signalling pathway leading
to protein synthesis in Lean and Obese Zucker rats after High force electrical stimulation
(HFES). Molecules shown in dark shaded, medium shaded and empty circles represent no
change, complete and incomplete activation, respectively. Molecules shown in dashed
rectangles were not measured in this study.
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Table 1
Body weight and muscle mass of lean and obese (fa/fa) Zucker rats.
Lean Zucker

Obese Zucker

Body mass, g

328 ± 12.2

597 ± 21.7*

TA mass, mg

651 ± 9.0

479 ± 20*

An asterisk (*) indicates significant difference (P < 0.05) from the lean Zucker value.

